NEW 305,024 New approaches to hematologic disorders and malignancies : recombinant human erythropoietin and 2-chlorodeoxyadeno-sine / supported by an educational grant from Ortho Biotech Inc. and the R.W. Johnson Pharmaceutical Research Institute, Raritan, Nj. - [Philadelphia] : W.B. Saunders Co. A Division of Harcourt Brace and Co., 1993. - [2], 33 s. : wykr. ; 28 cm (Seminars in Hematology, ISSN 0037-1963 ; vol.30, suppl.6)